Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy designed to reverse cellular aging in the human eye. The trial, registered as ...

A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in the human eye. The study, called ER-100, uses a gene therapy vector to ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.

A novel gene therapy that leads to cellular rejuvenation could restore vision after non-arteritic anterior ischemic optic neuropathy (NAION) and glaucoma. The technique is based on a reprogramming ...

It is well known that students who prepare in advance perform better on exams. Now, it appears that the skin can do the same. Rather than scrambling to repair itself only after injury occurs, a Korean ...

Beyond headlines and promises of eternal youth, advances in transplants, epigenetic clocks, and cellular reprogramming are redefining aging to help people live longer — and, above all, healthier. Some ...

Add Yahoo as a preferred source to see more of our stories on Google. Technologies to refresh ageing tissue have become attractive targets for investors. Yuancheng Ryan Lu could barely breathe while ...

It is well known that students who prepare in advance perform better in exams. Now, it appears that the skin can do the same. Rather than scrambling to repair itself only after injury occurs, a Korean ...